Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.

J Immunother Cancer 2020 Oct

Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.

Related Questions

Given the results of LU-002 presented at ASCO 2024, are there situations and/or patient subgroups who still derive benefit from local consolidative therapy for oliogmetastatic NSCLC?

New comment by Radiation Oncologist at Lake Huron Medical Center ( September 5, 2024)

What a great answer. Thanks for that

Read more (5 Answers available)